Search results
3 days ago · Pharmaniaga Berhad is an investment holding company. The Company, through its subsidiaries, manufactures, markets, and distributes pharmaceutical and medical products to government hospitals and ...
4 days ago · Pharmaniaga is 52%-owned by the recently delisted Boustead Holdings Bhd, which is 95.63%-owned by Lembaga Tabung Angkatan Tentera (LTAT) following its privatisation of the group. LTAT also has a direct 8.6% interest in Pharmaniaga. Pharmaniaga's shares closed three sen or 8.45% higher at 38.5 sen on Wednesday, valuing the group at RM504.43 million.
6 days ago · Pharmaniaga Berhad is an investment holding company. The Company is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company operates through three segments: Logistics and distribution, Manufacturing, and ...
Jun 12, 2024 · KUALA LUMPUR (Feb 22): Pharmaniaga Bhd has appointed Izaddeen Daud as its new non-independent non-executive chairman effective from Wednesday (Feb 22). He has served on the board of Pharmaniaga as a non-independent non-executive director since March 2021. Izaddeen, who is also Boustead Holdings Bhd's group chief executive officer, has held ...
Jun 12, 2024 · Pharmaniaga Berhad is an investment holding company. The Company is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy.
4 days ago · 1994. 3,476. n/a. www.pharmaniaga.com. Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading ...
Jun 24, 2024 · In its FY2021 annual report, Pharmaniaga says it had undertaken an impairment assessment amounting to RM200 million for its wholly-owned unit Pharmaniaga LifeScience Sdn Bhd (PLS) in Puchong - the subsidiary that is involved in the production of Covid-19 vaccines. Pharmaniaga had concluded that “no impairment loss was required for the ...
